Advertisement

Clinical and Translational Oncology

, Volume 18, Issue 5, pp 527–532 | Cite as

Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer

  • H. G. Zhang
  • X. W. Xu
  • X. P. Shi
  • B. W. Han
  • Z. H. Li
  • W. H. Ren
  • P. J. Chen
  • Y. F. Lou
  • B. Li
  • X. Y. Luo
Research Article

Abstract

Background

The forkhead box M1 (FOXM1), an important regulator of cell differentiation and proliferation, is overexpressed in a number of aggressive human carcinomas. However, the clinical significance of FOXM1 signaling in human colorectal cancer (CRC) pathogenesis remains unknown. The aim of this study was to evaluate the role of FOXM1 in CRC tumorigenesis.

Methods

We investigated FOXM1 expression in 103 cases of primary CRC and matched normal tissue specimens and explored the underlying mechanisms of altered FOXM1 expression and the impact of this altered expression on CRC proliferation and metastasis using in vitro models of CRC.

Results

The results showed that high expression of FOXM1 staining was 85.44 % (88/103) in 103 cases of CRC and 20.39 % (21/103) in 103 cases of adjacent non-cancerous tissue samples; the difference of FOXM1 expression between two groups was statistically significant (P < 0.001). Silencing of FOXM1 inhibited the proliferation of CRC cells, and the invasion and migration of CRC cells were distinctly suppressed. Furthermore, FOXM1 knockdown led to substantial reductions in VEGF-A levels in CRC cell lines.

Conclusions

Our data suggest that the pathogenesis of CRC maybe mediated by FOXM1, and FOXM1 could represent selective targets for the molecularly targeted treatments of CRC.

Keywords

Colorectal cancer Forkhead box protein M1 Small interfering RNA Targeted therapy 

Notes

Acknowledgments

This work is supported by the Bureau of Luoyang City Science and Technology 2015 Key Project Fund.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

References

  1. 1.
    Perencevich M, Stoffel EM. A multidisciplinary approach to the diagnosis and management of multiple colorectal polyps. Gastroenterol Hepatol. 2011;7:420.Google Scholar
  2. 2.
    Shelton BK. Introduction to colorectal cancer. Semin Oncol Nurs. 2002;18:2–12.CrossRefPubMedGoogle Scholar
  3. 3.
    Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–57.CrossRefPubMedGoogle Scholar
  4. 4.
    Koo CY, Muir KW, Lam EW. FOXM1: from cancer initiation to progression and treatment. Biochim Biophys Acta. 2012;1819:28–37.CrossRefGoogle Scholar
  5. 5.
    Katoh M. Human FOX gene family (review). Int J Oncol. 2004;5:1495–500.Google Scholar
  6. 6.
    Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 2002;62:4773–80.PubMedGoogle Scholar
  7. 7.
    Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, et al. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res. 2006;66:1712–20.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, et al. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res. 2006;66:3593–602.CrossRefPubMedGoogle Scholar
  9. 9.
    Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009;69:3501–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, Yao KM, et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem. 2006;281:25167–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, et al. The forkhead box M1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res. 2006;66:2153–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Jiang LZ, Wang P, Deng B, Huang C, Tang WX, Lu HY, et al. Overexpression of forkhead box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Hum Pathol. 2011;42:1185–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science. 1982;217:998–1003.CrossRefPubMedGoogle Scholar
  14. 14.
    Liotta LA, Steeq PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327–36.CrossRefPubMedGoogle Scholar
  15. 15.
    Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer. 2007;7:64–85.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Park HJ, Gusarova G, Wang Z, Carr JR, Li J, Kim KH, et al. Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med. 2011;1:21–34.CrossRefGoogle Scholar
  17. 17.
    Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161:1163–77.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201:1089–99.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2015

Authors and Affiliations

  • H. G. Zhang
    • 1
  • X. W. Xu
    • 2
  • X. P. Shi
    • 1
  • B. W. Han
    • 2
  • Z. H. Li
    • 2
  • W. H. Ren
    • 1
  • P. J. Chen
    • 1
  • Y. F. Lou
    • 1
  • B. Li
    • 1
  • X. Y. Luo
    • 1
  1. 1.Department of OncologyThe Affiliated Luoyang Central Hospital of Zhengzhou UniversityLuoyangChina
  2. 2.Department of SurgeryThe Affiliated Luoyang Central Hospital of Zhengzhou UniversityLuoyangChina

Personalised recommendations